Transient neonatal diabetes with two novel mutations in the KCNJ11 gene and response to sulfonylurea treatment in a preterm infant |
| |
Authors: | Siklar Zeynep Ellard Sian Okulu Emel Berbero?lu Merih Young Elizabeth Sava? Erdeve Senay Mungan Ilke Akin Hacihamdio?lu Bülent Erdeve Omer Arsan Saadet Oçal Gönül |
| |
Institution: | Ankara University School of Medicine, Ankara, Turkey. zeynepsklr@gmail.com |
| |
Abstract: | Neonatal diabetes mellitus (NDM) is a rare condition that can be either transient or permanent. K(ATP) channel (Kir6.2 or SUR1) mutation, chromosome 6 abnormalities, insulin, or glucokinase gene mutations can lead to isolated NDM. Cases caused by Kir6.2 mutation usually result in permanent NDM (PNDM) rather than transient NDM (TNDM). The majority of patients with the Kir6.2 or SUR1 mutation can be successfully managed with a sulfonylurea agent, without the need for insulin. We report a preterm male with NDM having two novel missense mutations, E322A and D352H, in the KCNJ11 gene. At 2 months of age, successful transition from insulin to glibenclamide (glyburide) therapy of the patient was managed. At 5 months of age, his diabetes went in to remission. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|